AusBiotech says EMDG provides critical support for biotech

12 March 2015

Trade group AusBiotech has submitted to the review of the Export Market Development Grants (EMDG) to note that the program provides critical support for Australian biotechnology businesses to enhance and establish new overseas markets for export and partnership and to attract foreign direct investment and skills into Australia.

AusBiotech said in its submission that biotechnology is an industry that is global in nature and relies on international trade and investment for success. It is also characterized by a large number of micro and small business in growth phases, which is good for Australia’s economic growth, but their size also provides challenges for the companies themselves in accessing global markets.

EMDG has enabled AusBiotech to run industry growth programs

This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.

Try before you buy

Free

7 day trial access

Take a Free Trial

All the news that moves the needle in pharma and biotech
Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
Receive The Pharma Letter daily news bulletin, free forever.

Become a subscriber

£820

Or £77 per month

Subscribe Now

Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
Daily roundup of key events in pharma and biotech.
Monthly in-depth briefings on Boardroom appointments and M&A news.
Choose from a cost-effective annual package or a flexible monthly subscription

The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed

Chairman, Sanofi Aventis UK